Denosumab (calcium and bone metabolism medicines)

Denosumab (calcium and bone metabolism medicines) is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about denosumab (calcium and bone metabolism medicines) automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain denosumab (calcium and bone metabolism medicines), including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - denosumab (calcium and bone metabolism medicines)


06 Apr 2017 Prolia Solution for injection is a brand of medicine containing the active ingredient denosumab (calcium & bone metabolism medicines). Find out about side effects, who can take it and who shouldn’t use Prolia Solution for injection by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Corporate information)
16 Feb 2017 We surveyed Australian general practitioners about their management of osteporosis after participating in an NPS educational visit on this topic. Read the results of the survey here.
For health professionals (Condition)
01 Oct 2015 Choose osteoporosis medicines based on clinical assessment of risk factors, absolute fracture risk and/or BMD measurement. Monitor for effectiveness and adherence.
06 Feb 2014 Your general heath and medicines can affect your oral health. To help your dentist make the best treatment decisions for you, they will need to know about all the medicines you are taking, and any medical conditions you have.
(Consumer publication)
16 Dec 2010 Information on denosumab, a medicine used for treatment of postmenopausal osteoporosis.

Medicine brands that contain denosumab (calcium and bone metabolism medicines)